首页>British Journal of Haematology>MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib
作者单位：Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy[1]Department of Life Sciences, University of Trieste, Trieste, Italy[2]Department of Morphology and Embryology and LTTA Centre, University of Ferrara, Ferrara, Italy[3]
换一批
